Abstract
Emergence of carbapenem-resistant Acinetobacter spp. has been increasingly reported worldwide. We report here the first detection of an Acinetobacter calcoaceticus isolate from vegetables in Lebanon carrying the blaOxa-72 gene. These findings show that the Lebanese environment may constitute a potential reservoir for this antibiotic resistance gene.
Keywords: Acinetobacter calcoaceticus, blaOxa-72, carbapenem resistance, Lebanon, vegetables
Acinetobacter calcoaceticus is a Gram-negative aerobic bacterium that belongs to the Acinetobacter calcoaceticus–Acinetobacter baumannii complex [1]. It is ubiquitous in nature and can be isolated from soil samples and vegetables [2], [3]. Even if A. baumannii is more able to cause infections with high mortality and morbidity, the role of A. calcoaceticus in nosocomial infections should not be underrated [4], [5]. Carbapenems have been widely used to treat infections caused by multidrug-resistant Acinetobacter. However, resistance to carbapenems among this genus has been increasingly reported during the last years, especially in A. baumannii, and is becoming a serious public health problem worldwide. Carbapenem-hydrolyzing class D β-lactamases and metallo-β-lactamases are the most frequently encountered enzymes within this genus [6]. Several studies have reported the isolation of carbapenem-resistant A. calcoaceticus from clinical and environmental samples [3], [5], [7].
In the present study, two imipenem-resistant A. calcoaceticus strains isolated in Lebanon from vegetables were analysed. Bacterial identification was initially performed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) and confirmed at the species level by partial rpoB gene sequencing, as previously described [2]. Antimicrobial susceptibility was determined by the disk diffusion method according to the recommendations of the European Committee on Antimicrobial Susceptibility Testing (http://www.eucast.org). Resistance to imipenem and meropenem was confirmed by the Etest method. Etest results confirmed the carbapenem-resistant phenotype because the minimum inhibitory concentrations for imipenem and meropenem were 16 mg/L. In addition, both strains remained susceptible against piperacillin/tazobactam, ceftazidime, aminosides, tigecycline, rifampin, ciprofloxacin and colistin.
Screening of blaOXA-23-like, blaOXA-24-like and blaOXA-58-like genes by real-time PCR revealed that both isolates carried the blaOXA-24-like gene and were negative for the other carbapenemase genes tested. Sequencing of the blaOxa-24-like gene showed that it encoded for the Oxa-72 variant. This variant was first described in 2004 in an A. baumannii isolate sampled in Thailand (GenBank accession no. AY739646.1). Since then, the variant has been reported worldwide from carbapenem-resistant clinical isolates of Acinetobacter spp. but has never been described in A. calcoaceticus [8], [9]. In our study, we found for the first time the presence of the blaOxa-72 variant in A. calcoaceticus isolated in Lebanon from two vegetables purchased from the same market in Beirut. Isolation of this multidrug-resistant bacterium may reflect a possible contamination of the environment surrounding the agriculture zones, such as irrigation water or the soil itself, or it may highlight the potential role of animals as a possible contributor of contamination.
One can presume that isolation of such multidrug-resistant bacteria in such an environment may be in part due to the uncontrolled use of antimicrobial agents, either in the food chain or to treat both humans and animals. Thus, this phenomenon could constitute a selective pressure for environmental bacteria, which then consequently makes the environment a potential reservoir for antibiotic resistance genes [10]. Therefore, appropriate strategies should be implemented to avoid excessive use of antimicrobial agents and to limit environmental contamination with multidrug-resistant bacteria.
Acknowledgements
The authors thank the Lebanese University and the National Council for Scientific Research, Lebanon, for their funding of this research.
Conflict of Interest
None declared.
References
- 1.Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21:538–582. doi: 10.1128/CMR.00058-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Rafei R., Hamze M., Pailhoriès H., Eveillard M., Marsollier L., Joly-Guillou M.-L. Extrahuman epidemiology of Acinetobacter baumannii in Lebanon. Appl Environ Microbiol. 2015;81:2359–2367. doi: 10.1128/AEM.03824-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Wang B., Sun D. Detection of NDM-1 carbapenemase-producing Acinetobacter calcoaceticus and Acinetobacter junii in environmental samples from livestock farms. J Antimicrob Chemother. 2015;70:611–613. doi: 10.1093/jac/dku405. [DOI] [PubMed] [Google Scholar]
- 4.Joly-Guillou M.L. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect. 2005;11:868–873. doi: 10.1111/j.1469-0691.2005.01227.x. [DOI] [PubMed] [Google Scholar]
- 5.Li P., Yang C., Xie J., Liu N., Wang H., Zhang L. Acinetobacter calcoaceticus from a fatal case of pneumonia harboring blaNDM-1 on a widely distributed plasmid. BMC Infect Dis. 2015;15:131. doi: 10.1186/s12879-015-0870-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Kempf M., Rolain J.M. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int J Antimicrob Agents. 2012;39:105–114. doi: 10.1016/j.ijantimicag.2011.10.004. [DOI] [PubMed] [Google Scholar]
- 7.Merino M., Acosta J., Poza M., Sanz F., Beceiro A., Chaves F. OXA-24 carbapenemase gene flanked by XerC/XerD-like recombination sites in different plasmids from different Acinetobacter species isolated during a nosocomial outbreak. Antimicrob Agents Chemother. 2010;54:2724–2727. doi: 10.1128/AAC.01674-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Fernández-Cuenca F., Rodríguez-Martínez J.M., Gómez-Sánchez M.A.C., de Alba P.D., Infante-Martínez V., Pascual A. Production of a plasmid-encoded OXA-72 β-lactamase associated with resistance to carbapenems in a clinical isolate Acinetobacter junii. Int J Antimicrob Agents. 2012;39:93–94. doi: 10.1016/j.ijantimicag.2011.07.017. [DOI] [PubMed] [Google Scholar]
- 9.Montealegre M.C., Maya J.J., Correa A., Espinal P., Mojica M.F., Ruiz S.J. First Identification of OXA-72 carbapenemase from Acinetobacter pittii in Colombia. Antimicrob Agents Chemother. 2012;56:3996–3998. doi: 10.1128/AAC.05628-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Roca I., Akova M., Baquero F., Carlet J., Cavaleri M., Coenen S. The global threat of antimicrobial resistance: science for intervention. New Microbes New Infect. 2015;6:22–29. doi: 10.1016/j.nmni.2015.02.007. [DOI] [PMC free article] [PubMed] [Google Scholar]